Analyst Ratings for Altimmune (ALT)
ALT Rating Summary
ALT Price Target Summary
- Highest: $24.00 (UBS)
- Lowest: $1.00 (Goldman Sachs)
- Average: $15.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.14 (+327.8%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 83%
Avg. $ Target:
$15.14 (+327.8%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Overweight (N/A) |
20.00 (N/A) |
5.66 (3.54) |
-37.46% | Details |
| 8/25/2025 | Evercore ISI » Updated 1/27/2026 |
Michael DiFiore | New Coverage | Outperform (N/A) |
22.00 (25.00) |
3.54 (3.54) |
0% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
